Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Heart Diseases × Methods × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 25 Neoplasms 23 Uterine Cervical Neoplasms 10 Lung Neoplasms 10 Colorectal Neoplasms 8 Colonic Neoplasms 8 Motor Activity 7 Urinary Bladder Neoplasms 6 Rectal Neoplasms 6 Vulvar Neoplasms 5 Obesity 5 Endometrial Neoplasms 5 Carcinoma, Non-Small-Cell Lung 5 Melanoma 4 Head and Neck Neoplasms 4 Anxiety Disorders 4 Stomach Neoplasms 3 Sarcoma 3 Hematopoietic and Lymphoid System Neoplasm 3 Depression 3 Carcinoma, Ovarian Epithelial 3 Breast Carcinoma In Situ 3 Vaginal Neoplasms 2 Testicular Neoplasms 2 Skin Neoplasms 2 Psychological Well-Being 2 Prostatic Neoplasms 2 Papillomavirus Infections 2 Pancreatic Neoplasms 2 Pain 2

Interventions

Echocardiography 2 liposomal doxorubicin 1 Vitamin E 1 Tomography, X-Ray Computed 1 Tomography, Emission-Computed 1 Surveys and Questionnaires 1 Positron-Emission Tomography 1 Nutrition Assessment 1 Methods 1 Magnetic Resonance Imaging 1 Interviews as Topic 1 Immunomodulating Agents 1 Immune Checkpoint Inhibitors 1 Hematologic Tests 1 Exercise Test 1 Educational Status 1 Breathing Exercises 1 Blood Specimen Collection 1 Aspirin 1 Antineoplastic Agents 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03750110 2022-05-19

YESS

University of Nottingham

Phase NA Completed

Heart Diseases, Lung Neoplasms, Respiration Disorders

Data powered by HemOnc (CC BY 4.0) Colophon ⚡